Green Cross Holdings
KRX:005250
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Green Cross Holdings
Accumulated Depreciation
Green Cross Holdings
Accumulated Depreciation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Green Cross Holdings
KRX:005250
|
Accumulated Depreciation
-₩561.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-12%
|
|
|
Celltrion Inc
KRX:068270
|
Accumulated Depreciation
-₩760.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-15%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Accumulated Depreciation
-₩6.6B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Accumulated Depreciation
-₩12.5B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Accumulated Depreciation
-₩12B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Accumulated Depreciation
-₩7.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Green Cross Holdings
Glance View
Green Cross Holdings Corp. is a holding company of Green Cross Corp. that engages in the manufacture of pharmaceutical products. The company is headquartered in Yongin, Gyeonggi-Do. The Company’s products portfolio consists of prescription drugs, blood derivatives, vaccines, cerebrovascular disease treatment, hunter syndrome drugs, as well as over the counter (OTC) drugs, such as skin disease treatment drugs, allergic cream and others. Its products are used for analgesic, treatment of cerebral thrombosis, hypoalbuminemia, genodermatosis and others, as well as prevention of influenza, prophylaxis of varicella, among others. The firm is also involved in the real estate sales and leasing, as well as construction business.
See Also
What is Green Cross Holdings's Accumulated Depreciation?
Accumulated Depreciation
-561.8B
KRW
Based on the financial report for Dec 31, 2025, Green Cross Holdings's Accumulated Depreciation amounts to -561.8B KRW.
What is Green Cross Holdings's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 10Y
-12%
Over the last year, the Accumulated Depreciation growth was -9%. The average annual Accumulated Depreciation growth rates for Green Cross Holdings have been -10% over the past three years , -11% over the past five years , and -12% over the past ten years .
